中文 | English
Return
Total: 167 , 1/17
Show Home Prev Next End page: GO
Author:( Shuling WANG)

1.Effects of parthenolide on systemic inflammation and intestinal injury in rats with acute pancreatitis

Yanan ZHAO ; Rui ZHANG ; Shuling WANG ; Chunchun YANG ; Yang WANG ; Mingyue YANG

China Pharmacy 2025;36(6):704-709

3.Study on Modification of Dosage Forms of Guoganglong Tablets and Comparison between New and Old Dosage Forms

Guantian DENG ; Yuxiang SUN ; Yunxia TENG ; Zhizhong LIAO ; Shuling WANG

Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(1):204-213

4.Summary of Huang Shuling's Experience in Treating Diabetic Foot Ulcers

Wenli WANG ; Huiyuan TAO ; Yuqing ZHOU ; Shuling HUANG

Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(3):752-756

5.Impact of health education interventions on the proper use of respiratory protective equipment among dust-exposed workers

Yuhao WANG ; Zhao ZHANG ; Jinyi LU ; Shanyu ZHOU ; Xiaoxin LI ; Zhiming ZHUANG ; Manjia GONG ; Qiaoli WEI ; Shuling HUANG ; Luyao XU ; Xudong LI

China Occupational Medicine 2025;52(5):552-557

6.Influencing factors of adaptive ability development of children aged 2 - 6 in China

Jiayin CUI ; Ruili LI ; Lihong WANG ; Xiaoguo ZHENG ; Huimin YANG ; Liqi ZHU ; Shuling GUO ; Lu ZHAO ; Wenhua ZHAO ; Zhenyu YANG ; Qian ZHANG ; Yuying WANG ; Tao XU ; Bowen CHEN

Chinese Journal of Child Health Care 2024;32(3):280-285

7.Cost-effectiveness Analysis of Recombinant Human Thrombopoietin Combined with Conventional Regimen in the Treatment of Sepsis-Associated Thrombocytopeni

Yuxin TANG ; Tianyu GAN ; Shuling WANG

Chinese Health Economics 2024;43(10):54-61

8.Quantitative evaluation of “dual channel”management policy of national medical insurance negotiation drugs based on PMC index model

Wenping GAO ; Shuling WANG

China Pharmacy 2024;35(19):2335-2339

9.Cost-effectiveness Analysis of Recombinant Human Thrombopoietin Combined with Conventional Regimen in the Treatment of Sepsis-Associated Thrombocytopeni

Yuxin TANG ; Tianyu GAN ; Shuling WANG

Chinese Health Economics 2024;43(10):54-61

10.Cost-effectiveness Analysis of Recombinant Human Thrombopoietin Combined with Conventional Regimen in the Treatment of Sepsis-Associated Thrombocytopeni

Yuxin TANG ; Tianyu GAN ; Shuling WANG

Chinese Health Economics 2024;43(10):54-61

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 167 , 1/17 Show Home Prev Next End page: GO